Skip to main content
Top
Published in: Archives of Osteoporosis 1/2021

01-12-2021 | Ankylosing Spondylitis | Original Article

A 2-year longitudinal study of bone health in adolescent patients with axial spondyloarthritis

Authors: Shin-Hee Kim, Ki Hwan Kim, Moon-Young Kim, Yeon Sik Hong, Kwi Young Kang

Published in: Archives of Osteoporosis | Issue 1/2021

Login to get access

Abstract

Purpose

Axial spondyloarthritis (axSpA) is a chronic inflammatory disease that primarily affects the axial skeleton and typically has an early onset. Although earlier onset is associated with worse prognosis, there have been few studies of bone mineral density (BMD) in adolescent patients with axSpA.

Methods

We analysed the clinical characteristics of 43 adolescent patients with axSpA at a baseline assessment and at a follow-up 2 years later. The baseline assessment included age, disease duration, treatment agents, and clinical, radiologic, and laboratory data. BMD of the lumbar spine, femoral neck, and total hip were measured by dual-energy X-ray absorptiometry during both the baseline assessment and the 2-year follow-up. We performed multivariate linear regression analyses to identify factors independently associated with BMD. We analysed the associations between changes in BMD and reductions in inflammatory markers.

Results

The average age of participants was 17.9 years and the mean disease duration was 2.2 years. Of the 43 patients, 10 (23%) had low BMD at any site (lumbar spine, femoral neck, and/or total hip). At baseline, multivariate analysis showed that body mass index (BMI), erythrocyte sedimentation rate (ESR), and spinal structural damage were associated with lumbar spine Z-scores. Increases in BMD in the lumbar spine were correlated with reductions in ESR (r = 0.40, P = 0.02) and C-reactive protein (CRP) (r = 0.40, P = 0.02). Increases in BMD in the total hip were correlated with reductions in CRP (r = 0.38, P = 0.03).

Conclusion

In adolescent axSpA patients, bone health was associated with systemic inflammation and the severity of structural damage. Reduced systemic inflammation was associated with improvements in bone health.
Literature
1.
go back to reference Weiss PF, Colbert RA (2018) Juvenile spondyloarthritis: a distinct form of juvenile arthritis. Pediatr Clin N Am 65:675–690CrossRef Weiss PF, Colbert RA (2018) Juvenile spondyloarthritis: a distinct form of juvenile arthritis. Pediatr Clin N Am 65:675–690CrossRef
3.
go back to reference Bao J, Chen Y, Bao Y-X (2014) Prevalence and risk factors of low bone mineral density in juvenile onset ankylosing spondylitis. Calcif Tissue Int 95:108–111CrossRefPubMed Bao J, Chen Y, Bao Y-X (2014) Prevalence and risk factors of low bone mineral density in juvenile onset ankylosing spondylitis. Calcif Tissue Int 95:108–111CrossRefPubMed
4.
go back to reference Maillefert JF, Aho LS, El Maghraoui A, Dougados M, Roux C (2001) Changes in bone density in patients with ankylosing spondylitis: a two-year follow-up study. Osteoporos Int 12:605–609CrossRefPubMed Maillefert JF, Aho LS, El Maghraoui A, Dougados M, Roux C (2001) Changes in bone density in patients with ankylosing spondylitis: a two-year follow-up study. Osteoporos Int 12:605–609CrossRefPubMed
5.
go back to reference Mitra D, Elvins DM, Collins AJ (1999) Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures. J Rheumatol 26:2201–2204PubMed Mitra D, Elvins DM, Collins AJ (1999) Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures. J Rheumatol 26:2201–2204PubMed
6.
7.
go back to reference Kang KY, Kim IJ, Park S-H, Hong YS (2018) Associations between trabecular bone score and vertebral fractures in patients with axial spondyloarthritis. Rheumatology (Oxford) 57:1033–1040CrossRef Kang KY, Kim IJ, Park S-H, Hong YS (2018) Associations between trabecular bone score and vertebral fractures in patients with axial spondyloarthritis. Rheumatology (Oxford) 57:1033–1040CrossRef
8.
go back to reference Thornton J, Pye SR, O’Neill TW, Rawlings D, Francis RM, Symmons DPM et al (2011) Bone health in adult men and women with a history of juvenile idiopathic arthritis. J Rheumatol 38:1689–1693CrossRefPubMed Thornton J, Pye SR, O’Neill TW, Rawlings D, Francis RM, Symmons DPM et al (2011) Bone health in adult men and women with a history of juvenile idiopathic arthritis. J Rheumatol 38:1689–1693CrossRefPubMed
9.
go back to reference Kang KY, Chung MK, Kim HN, Hong YS, Ju JH, Park S-H (2018) Severity of sacroiliitis and erythrocyte sedimentation rate are associated with a low trabecular bone score in young male patients with ankylosing spondylitis. J Rheumatol 45:349–356CrossRefPubMed Kang KY, Chung MK, Kim HN, Hong YS, Ju JH, Park S-H (2018) Severity of sacroiliitis and erythrocyte sedimentation rate are associated with a low trabecular bone score in young male patients with ankylosing spondylitis. J Rheumatol 45:349–356CrossRefPubMed
10.
go back to reference Rudwaleit M, Landewé R, van der Heijde D, Listing J, Brandt J, Braun J et al (2009) The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 68:770–776CrossRefPubMed Rudwaleit M, Landewé R, van der Heijde D, Listing J, Brandt J, Braun J et al (2009) The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 68:770–776CrossRefPubMed
11.
go back to reference Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291PubMed Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291PubMed
12.
go back to reference Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285PubMed Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285PubMed
13.
go back to reference van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J et al (2009) ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68:1811–1818CrossRefPubMed van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J et al (2009) ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68:1811–1818CrossRefPubMed
14.
go back to reference Baim S, Leonard MB, Bianchi M-L, Hans DB, Kalkwarf HJ, Langman CB, Rauch F (2008) Official positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference. J Clin Densitom 11:6–21CrossRefPubMed Baim S, Leonard MB, Bianchi M-L, Hans DB, Kalkwarf HJ, Langman CB, Rauch F (2008) Official positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference. J Clin Densitom 11:6–21CrossRefPubMed
15.
go back to reference Averns HL, Oxtoby J, Taylor HG, Jones PW, Dziedzic K, Dawes PT (1996) Radiological outcome in ankylosing spondylitis: use of the Stoke Ankylosing Spondylitis Spine Score (SASSS). Br J Rheumatol 35:373–376CrossRefPubMed Averns HL, Oxtoby J, Taylor HG, Jones PW, Dziedzic K, Dawes PT (1996) Radiological outcome in ankylosing spondylitis: use of the Stoke Ankylosing Spondylitis Spine Score (SASSS). Br J Rheumatol 35:373–376CrossRefPubMed
16.
go back to reference van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368CrossRefPubMed van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368CrossRefPubMed
17.
go back to reference Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor ME, Woo P, International League of Associations for Rheumatology (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390–392PubMed Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor ME, Woo P, International League of Associations for Rheumatology (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390–392PubMed
18.
go back to reference Gensler L, Davis JC (2006) Recognition and treatment of juvenile-onset spondyloarthritis. Curr Opin Rheumatol 18:507–511CrossRefPubMed Gensler L, Davis JC (2006) Recognition and treatment of juvenile-onset spondyloarthritis. Curr Opin Rheumatol 18:507–511CrossRefPubMed
20.
go back to reference Robinson Y, Sandén B, Olerud C (2013) Increased occurrence of spinal fractures related to ankylosing spondylitis: a prospective 22-year cohort study in 17,764 patients from a national registry in Sweden. Patient Saf Surg 7:2CrossRefPubMedPubMedCentral Robinson Y, Sandén B, Olerud C (2013) Increased occurrence of spinal fractures related to ankylosing spondylitis: a prospective 22-year cohort study in 17,764 patients from a national registry in Sweden. Patient Saf Surg 7:2CrossRefPubMedPubMedCentral
21.
go back to reference Kang KY, Kim IJ, Jung SM, Kwok S-K, Ju JH, Park K-S et al (2014) Incidence and predictors of morphometric vertebral fractures in patients with ankylosing spondylitis. Arthritis Res Ther 16:R124CrossRefPubMedPubMedCentral Kang KY, Kim IJ, Jung SM, Kwok S-K, Ju JH, Park K-S et al (2014) Incidence and predictors of morphometric vertebral fractures in patients with ankylosing spondylitis. Arthritis Res Ther 16:R124CrossRefPubMedPubMedCentral
22.
go back to reference van der Weijden MAC, van Denderen JC, Lems WF, Heymans MW, Dijkmans BAC, van der Horst-Bruinsma IE (2011) Low bone mineral density is related to male gender and decreased functional capacity in early spondylarthropathies. Clin Rheumatol 30:497–503CrossRefPubMed van der Weijden MAC, van Denderen JC, Lems WF, Heymans MW, Dijkmans BAC, van der Horst-Bruinsma IE (2011) Low bone mineral density is related to male gender and decreased functional capacity in early spondylarthropathies. Clin Rheumatol 30:497–503CrossRefPubMed
23.
go back to reference Kang KY, Kwok S-K, Ju JH, Hong YS, Park S-H (2016) Assessment of fracture risk in patients with axial spondyloarthritis: a case–control study using the fifth Korean National Health and Nutrition Examination Survey (KNHANES V). Scand J Rheumatol. Taylor & Francis 45:23–31CrossRefPubMed Kang KY, Kwok S-K, Ju JH, Hong YS, Park S-H (2016) Assessment of fracture risk in patients with axial spondyloarthritis: a case–control study using the fifth Korean National Health and Nutrition Examination Survey (KNHANES V). Scand J Rheumatol. Taylor & Francis 45:23–31CrossRefPubMed
24.
go back to reference Aydin T, Karacan I, Demir SE, Sahin Z (2005) Bone loss in males with ankylosing spondylitis: its relation to sex hormone levels. Clin Endocrinol 63:467–469CrossRef Aydin T, Karacan I, Demir SE, Sahin Z (2005) Bone loss in males with ankylosing spondylitis: its relation to sex hormone levels. Clin Endocrinol 63:467–469CrossRef
25.
go back to reference Raisz LG (1988) Local and systemic factors in the pathogenesis of osteoporosis. N Engl J Med 318:818–828CrossRefPubMed Raisz LG (1988) Local and systemic factors in the pathogenesis of osteoporosis. N Engl J Med 318:818–828CrossRefPubMed
26.
go back to reference Lange U, Teichmann J, Strunk J, Müller-Ladner U, Schmidt KL (2005) Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis. Osteoporos Int 16:1999–2004CrossRefPubMed Lange U, Teichmann J, Strunk J, Müller-Ladner U, Schmidt KL (2005) Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis. Osteoporos Int 16:1999–2004CrossRefPubMed
27.
go back to reference Gratacós J, Collado A, Pons F, Osaba M, Sanmartí R, Roqué M et al (1999) Significant loss of bone mass in patients with early, active ankylosing spondylitis: a followup study. Arthritis Rheum 42:2319–2324CrossRefPubMed Gratacós J, Collado A, Pons F, Osaba M, Sanmartí R, Roqué M et al (1999) Significant loss of bone mass in patients with early, active ankylosing spondylitis: a followup study. Arthritis Rheum 42:2319–2324CrossRefPubMed
28.
go back to reference Kang KY, Lee KY, Kwok S-K, Ju JH, Park K-S, Hong YS, Kim HY, Park SH (2011) The change of bone mineral density according to treatment agents in patients with ankylosing spondylitis. Joint Bone Spine 78:188–193CrossRefPubMed Kang KY, Lee KY, Kwok S-K, Ju JH, Park K-S, Hong YS, Kim HY, Park SH (2011) The change of bone mineral density according to treatment agents in patients with ankylosing spondylitis. Joint Bone Spine 78:188–193CrossRefPubMed
29.
go back to reference Tang T, Tang X, Xu L, Huang Y, Zeng J, Li Q (2015) Evaluation of bone mass in children and young adults with juvenile idiopathic arthritis. Clin Exp Rheumatol 33:758–764PubMed Tang T, Tang X, Xu L, Huang Y, Zeng J, Li Q (2015) Evaluation of bone mass in children and young adults with juvenile idiopathic arthritis. Clin Exp Rheumatol 33:758–764PubMed
30.
go back to reference Cimaz R (2002) Osteoporosis in childhood rheumatic diseases: prevention and therapy. Best Pract Res Clin Rheumatol 16:397–409CrossRefPubMed Cimaz R (2002) Osteoporosis in childhood rheumatic diseases: prevention and therapy. Best Pract Res Clin Rheumatol 16:397–409CrossRefPubMed
31.
go back to reference Cetin A, Celiker R, Dinçer F, Ariyürek M (1998) Bone mineral density in children with juvenile chronic arthritis. Clin Rheumatol 17:551–553CrossRefPubMed Cetin A, Celiker R, Dinçer F, Ariyürek M (1998) Bone mineral density in children with juvenile chronic arthritis. Clin Rheumatol 17:551–553CrossRefPubMed
32.
go back to reference Kang KY, Ju JH, Park S-H, Kim H-Y (2013) The paradoxical effects of TNF inhibitors on bone mineral density and radiographic progression in patients with ankylosing spondylitis. Rheumatology. 52:718–726CrossRefPubMed Kang KY, Ju JH, Park S-H, Kim H-Y (2013) The paradoxical effects of TNF inhibitors on bone mineral density and radiographic progression in patients with ankylosing spondylitis. Rheumatology. 52:718–726CrossRefPubMed
33.
go back to reference Poddubnyy D, Hermann K-GA, Callhoff J, Listing J, Sieper J (2014) Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS). Ann Rheum Dis 73:817–823CrossRefPubMed Poddubnyy D, Hermann K-GA, Callhoff J, Listing J, Sieper J (2014) Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS). Ann Rheum Dis 73:817–823CrossRefPubMed
34.
go back to reference Baeten D, Baraliakos X, Braun J, Sieper J, Emery P, van der Heijde D, McInnes I, van Laar JM, Landewé R, Wordsworth P, Wollenhaupt J, Kellner H, Paramarta J, Wei J, Brachat A, Bek S, Laurent D, Li Y, Wang YA, Bertolino AP, Gsteiger S, Wright AM, Hueber W (2013) Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial. Lancet 382:1705–1713CrossRefPubMed Baeten D, Baraliakos X, Braun J, Sieper J, Emery P, van der Heijde D, McInnes I, van Laar JM, Landewé R, Wordsworth P, Wollenhaupt J, Kellner H, Paramarta J, Wei J, Brachat A, Bek S, Laurent D, Li Y, Wang YA, Bertolino AP, Gsteiger S, Wright AM, Hueber W (2013) Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial. Lancet 382:1705–1713CrossRefPubMed
35.
go back to reference Pathan E, Abraham S, Van Rossen E, Withrington R, Keat A, Charles PJ et al (2013) Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis. Ann Rheum Dis 72:1475–1480CrossRefPubMed Pathan E, Abraham S, Van Rossen E, Withrington R, Keat A, Charles PJ et al (2013) Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis. Ann Rheum Dis 72:1475–1480CrossRefPubMed
Metadata
Title
A 2-year longitudinal study of bone health in adolescent patients with axial spondyloarthritis
Authors
Shin-Hee Kim
Ki Hwan Kim
Moon-Young Kim
Yeon Sik Hong
Kwi Young Kang
Publication date
01-12-2021
Publisher
Springer London
Published in
Archives of Osteoporosis / Issue 1/2021
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI
https://doi.org/10.1007/s11657-020-00860-y

Other articles of this Issue 1/2021

Archives of Osteoporosis 1/2021 Go to the issue